Annual report [Section 13 and 15(d), not S-K Item 405]

OTHER LIABILITIES (Tables)

v3.26.1
OTHER LIABILITIES (Tables)
12 Months Ended
Mar. 31, 2026
Other Liabilities Disclosure [Abstract]  
Schedule of other liabilities
As of March 31, 2026 and 2025, other liabilities of the Company included the following:
March 31, 2026 March 31, 2025
Loans received $ 96,771  $ 24,860 
Financial liability measured at fair value 66,662  32,087 
Vacation reserve 21,333  11,698 
Salaries and other employee benefits 20,787  17,326 
Payable to suppliers 14,405  9,815 
Other advances received 12,077  3,683 
Taxes payable other than income tax 11,778  6,338 
Reserves for contingent liabilities 10,000  — 
Deferred income tax liabilities 6,552  62 
Outstanding settlements operations 448  — 
Deferred distribution payments 156  156 
Payable for acquisition —  2,672 
Other 24,278  21,040 
Total other liabilities $ 285,247  $ 129,737 
Schedule of outstanding debt securities of company
As of March 31, 2026 and 2025, outstanding debt securities of the Group included the following:
Debt securities issued by:
Principal Amount as of March 31, 2026
Principal Amount as of March 31, 2025
Interest rate Issue date Maturity date Denominated Currency
Freedom SPC bonds due 2028 $ 269,722  $ — 
9.5%
October, 2025 October, 2028
USD
Freedom SPC bonds due 2028 200,170  200,305 
1-2 years: 12%
3-5years: 10.39%
December, 2023 December, 2028
USD
Freedom SPC bonds due 2026 199,344  201,311 
10.5%
September, 2024 September, 2026
USD
Freedom SPC bonds due 2027 198,492  — 
10.0%
May, 2025 May, 2027
USD
Freedom SPC bonds due 2029 186,502  — 
9.0%
March, 2026 March, 2029
USD
Freedom SPC bonds due 2027 98,982  — 
8.0%
May, 2025 May, 2027
EUR
Freedom SPC bonds due 2026 65,057  64,801 
 5.5%
October, 2021 October, 2026
USD
Freedom SPC bonds due 2027 30,676  — 
9.0%
May, 2025 May, 2027
CNY
Accrued interest 12,175  3,134 
Total debt securities issued $ 1,261,120  $ 469,551 
Table below represents loans received by the Company as of March 31, 2026 and 2025:

Lender Issue date Amount Interest rate Maturity date Denominated currency
Development Bank of Kazakhstan JSC
September 2024 12,062  10.0  % April 2027 KZT
JSC "Agrarian Credit Corporation" January 2026 13,733  1.5  % March 2027 KZT
JSC "Agrarian Credit Corporation" December 2025 16,292  1.5  % December 2040 KZT
“Damu” Entrepreneurship Development May 2025 22,095  2.0  % May 2040 KZT
“Damu” Entrepreneurship Development August 2025 9,444  2.0  % May 2040 KZT
“Damu” Entrepreneurship Development May 2025 1,044  3.5  % December 2031 KZT
“Damu” Entrepreneurship Development October, 2025 11,784  2.0  % September 2035 KZT
“Damu” Entrepreneurship Development November, 2025 9,103  2.0  % September 2035 KZT
Other
October 2020
1,214 
20%, 38%
December 2028 KZT, TRY
Total loans received $ 96,771 

Lender Issue date Amount Interest rate Maturity date Denominated currency
Development Bank of Kazakhstan JSC
September 2024 $ 13,815  10.0  % April 2027 KZT
JSC "Agrarian Credit Corporation" March 2025 6,938  1.5  % February 2026 KZT
JSC "Agrarian Credit Corporation" December 2024 3,965  1.5  % February 2026 KZT
Other 142 
Total loans received $ 24,860 

Schedule of derivative instruments
The following table presents the fair value of derivative instruments as of March 31, 2026 and 2025:
March 31, 2026 March 31, 2025
Structured product financial liabilities measured at fair value 63,861  32,087 
Total $ 63,861  $ 32,087 

The following table presents the effect of structured product financial liabilities on the consolidated statements of operations:
Year ended
March 31, 2026
Year ended
March 31, 2025
Year ended
March 31, 2024
Net gain on structured product financial liabilities $ 13,976  $ 4,474  $ 103 
Total $ 13,976  $ 4,474  $ 103 
Schedule of reconciliation of changes in Level 3 derivative liabilities
The following table provides a reconciliation of changes in Level 3 derivative liabilities:
Year ended
March 31, 2026
Year ended
March 31, 2025
Balance at beginning of period $ 26,892  $ 1,683 
Issuances (origination of contracts) 59,770  35,305 
Settlements and terminations (32,453) (4,142)
Net (gains) on structured products recognized in earnings (14,256) (5,954)
Balance at end of period $ 39,953  $ 26,892 
Schedule of fair value measurement inputs and valuation techniques
Valuation technique Significant unobservable input Range / weighted average
PHX structured derivative liabilities Simulation-based and option-pricing models Internally developed volatility
1.4% to (44)% p.a./ 7.2%